Athersys, Inc. (ATHX): Price and Financial Metrics


Athersys, Inc. (ATHX): $0.18

0.00 (-0.22%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ATHX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ATHX POWR Grades


  • Growth is the dimension where ATHX ranks best; there it ranks ahead of 53.09% of US stocks.
  • The strongest trend for ATHX is in Growth, which has been heading up over the past 179 days.
  • ATHX ranks lowest in Momentum; there it ranks in the 8th percentile.

ATHX Stock Summary

  • Of note is the ratio of Athersys Inc's sales and general administrative expense to its total operating expenses; merely 8.86% of US stocks have a lower such ratio.
  • With a price/sales ratio of 27.92, Athersys Inc has a higher such ratio than 94.37% of stocks in our set.
  • Revenue growth over the past 12 months for Athersys Inc comes in at 282.92%, a number that bests 97.12% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Athersys Inc are IMGN, JNCE, MGNX, LPTX, and XENE.
  • Visit ATHX's SEC page to see the company's official filings. To visit the company's web site, go to www.athersys.com.

ATHX Valuation Summary

  • ATHX's price/sales ratio is 280.3; this is 2369.6% higher than that of the median Healthcare stock.
  • Over the past 173 months, ATHX's EV/EBIT ratio has gone down 3.5.
  • ATHX's price/sales ratio has moved up 279.6 over the prior 173 months.

Below are key valuation metrics over time for ATHX.

Stock Date P/S P/B P/E EV/EBIT
ATHX 2021-08-31 280.3 12.2 -4.1 -3.6
ATHX 2021-08-30 272.0 11.9 -3.9 -3.4
ATHX 2021-08-27 265.3 11.6 -3.8 -3.3
ATHX 2021-08-26 258.6 11.3 -3.7 -3.2
ATHX 2021-08-25 258.6 11.3 -3.7 -3.2
ATHX 2021-08-24 263.6 11.5 -3.8 -3.3

ATHX Growth Metrics

    Its year over year net cashflow from operations growth rate is now at -59.37%.
  • Its 4 year price growth rate is now at 17.41%.
  • Its 3 year cash and equivalents growth rate is now at 67.75%.
Over the past 70 months, ATHX's revenue has gone down $21,161,000.

The table below shows ATHX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 5.514 -76.185 -86.955
2021-09-30 6.062 -74.126 -87.45
2021-06-30 1.356 -74.157 -93.816
2021-03-31 1.44 -66.8 -89.589
2020-12-31 1.44 -61.81 -78.765
2020-09-30 0.457 -54.688 -66.482

ATHX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ATHX has a Quality Grade of C, ranking ahead of 38.11% of graded US stocks.
  • ATHX's asset turnover comes in at 0.02 -- ranking 368th of 682 Pharmaceutical Products stocks.
  • INFI, NLTX, and LCTX are the stocks whose asset turnover ratios are most correlated with ATHX.

The table below shows ATHX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.020 1 7.687
2021-03-31 0.020 1 6.179
2020-12-31 0.023 1 6.796
2020-09-30 0.008 1 7.038
2020-06-30 0.000 1 6.688
2020-03-31 0.092 1 6.754

ATHX Price Target

For more insight on analysts targets of ATHX, see our ATHX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $5.75 Average Broker Recommendation 1.38 (Strong Buy)

ATHX Stock Price Chart Interactive Chart >

Price chart for ATHX

ATHX Price/Volume Stats

Current price $0.18 52-week high $1.81
Prev. close $0.18 52-week low $0.18
Day low $0.18 Volume 1,876,548
Day high $0.19 Avg. volume 3,204,964
50-day MA $0.56 Dividend yield N/A
200-day MA $1.00 Market Cap 46.49M

Athersys, Inc. (ATHX) Company Bio


Athersys, Inc. focuses on the research and development activities in the field of regenerative medicine. The company was founded in 1995 and is based in Cleveland, Ohio.


ATHX Latest News Stream


Event/Time News Detail
Loading, please wait...

ATHX Latest Social Stream


Loading social stream, please wait...

View Full ATHX Social Stream

Latest ATHX News From Around the Web

Below are the latest news stories about Athersys Inc that investors may wish to consider to help them evaluate ATHX as an investment opportunity.

Is Athersys, Inc. (ATHX) Stock Outpacing Its Medical Peers This Year?

Here is how Athersys, Inc. (ATHX) and Gamida Cell (GMDA) have performed compared to their sector so far this year.

Yahoo | February 23, 2022

Athersys CEO Daniel Camardo's stock option grant worth $8.6 million

Companies often use inducement grants to hire top executives when they lack enough shares in their equity reserves to accommodate large grants.

Yahoo | February 18, 2022

Athersys Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, February 17, 2022--Athersys Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4). Stock Option Award Offered to Daniel Camardo, new Chief Executive Officer.

Yahoo | February 17, 2022

Athersys to Host Year-End 2021 Financial Results Call

CLEVELAND, February 15, 2022--Athersys to Host Year-End 2021 Financial Results Call; New CEO, Daniel A. Camardo, and Management to Host Conference Call on March 15, 2022

Yahoo | February 15, 2022

Is Amneal Pharmaceuticals (AMRX) Stock Outpacing Its Medical Peers This Year?

Here is how Amneal Pharmaceuticals (AMRX) and Athersys, Inc. (ATHX) have performed compared to their sector so far this year.

Yahoo | February 4, 2022

Read More 'ATHX' Stories Here

ATHX Price Returns

1-mo -65.40%
3-mo -80.65%
6-mo -82.52%
1-year -89.22%
3-year -90.00%
5-year -87.32%
YTD -80.06%
2021 -48.42%
2020 42.28%
2019 -14.58%
2018 -20.44%
2017 18.30%

Continue Researching ATHX

Here are a few links from around the web to help you further your research on Athersys Inc's stock as an investment opportunity:

Athersys Inc (ATHX) Stock Price | Nasdaq
Athersys Inc (ATHX) Stock Quote, History and News - Yahoo Finance
Athersys Inc (ATHX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6151 seconds.